How to legally get Mounjaro online in New York

In the rapidly evolving landscape of healthcare, telehealth has emerged as a convenient option for accessing medical care, including treatment for weight management. With the growing popularity of GLP-1 medications like Wegovy, Ozempic, and Mounjaro for weight loss, many patients wonder if they can obtain these prescriptions without an in-person visit. The short answer is yes—in most cases, you can legally get weight loss medications through telehealth in the United States, though specific rules vary by state.

Understanding Telehealth Prescribing of Weight Loss Medications

GLP-1 agonists (glucagon-like peptide-1 receptor agonists) have revolutionized weight management by regulating blood sugar and reducing appetite. Unlike older weight loss medications that were controlled substances, these newer options are not controlled under federal law, which significantly impacts how they can be prescribed.

Key fact: Because medications like Wegovy and Ozempic are non-controlled substances, federal law does not require an in-person visit before prescribing them. This creates a favorable landscape for telehealth prescriptions, though state laws add important nuances.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal vs. State Regulations: What You Need to Know

Federal Rules

At the federal level, there are no barriers to prescribing non-controlled weight loss medications like GLP-1s via telehealth. The Ryan Haight Act, which requires in-person examinations before prescribing controlled substances, doesn’t apply to these medications.

For context, during the COVID-19 pandemic, the DEA temporarily waived in-person requirements even for controlled medications. As of December 2025, these flexibilities remain in place for controlled substances through the end of the year, though this doesn’t directly affect GLP-1 medications since they were never restricted at the federal level.

State-by-State Variations

While federal law permits telehealth prescribing of weight loss medications, state regulations create a patchwork of requirements across the country. Here’s what you need to know about some key states:

States with No In-Person Requirements

These states allow fully virtual care for weight loss medications:

• California: Telehealth prescribing is explicitly permitted with no in-person requirement
• Connecticut: No in-person mandate, though behavioral counseling must be included
• Florida: Physical exams can be conducted virtually, but follow-ups every 3 months are required
• Illinois: No in-person requirement for GLP-1 prescriptions
• New York: Telehealth-only care is permitted for weight management
• Washington: No special restrictions on telehealth for weight loss medications

States Requiring Initial In-Person Visits

Some states mandate an initial in-person evaluation before transitioning to telehealth:

• Arkansas: First examination must be conducted in-person
• Delaware: Initial physical exam required before telehealth prescribing
• Georgia: In-person exam required prior to telehealth prescriptions
• Mississippi: Must see patient once in-person before telehealth management
• New Jersey: Comprehensive in-person exam and labs required initially
• North Dakota: In-person initial evaluation expected for weight loss treatment
• South Carolina: Must examine patient in person first
• Texas: Initial in-person exam generally expected prior to telehealth prescribing
• Utah: Initial in-person exam encouraged
• Virginia: Must perform physical exam and labs initially

Provider Qualifications: Who Can Prescribe Via Telehealth?

Another important consideration is who can legally prescribe these medications. The rules vary by state:

• Medical Doctors (MDs) and Doctors of Osteopathy (DOs) can prescribe GLP-1 medications in all states, provided they’re licensed where the patient resides.

• Nurse Practitioners (NPs) can prescribe these medications in all states, but their level of independence varies:

• Independent Practice States: NPs can prescribe without physician oversight in states like California, New York, Washington, and many others

• Collaborative Practice States: NPs require physician agreements in states like Texas, Florida, and Pennsylvania

• Physician Assistants (PAs) generally need some level of physician supervision across all states when prescribing medications.

At Klarity Health, we ensure all our providers are appropriately licensed and credentialed in the states where they practice, giving you peace of mind about the legitimacy of your care.

Common Misconceptions About Telehealth Weight Loss Treatment

Myth: Anyone can get weight loss medications online for cosmetic purposes.

Reality: Reputable telehealth providers like Klarity Health conduct thorough evaluations to determine medical necessity. Generally, patients must have a BMI of 30 or higher (or 27+ with weight-related conditions) to qualify for these medications. Providers typically require detailed health information and may request lab work before prescribing.

Myth: These are ‘quick fix’ diet pills like older weight loss drugs.

Reality: GLP-1 agonists work differently than stimulant diet pills of the past. They require regular monitoring, take time to show results (typically gradual weight loss over months), and work best as part of a comprehensive treatment plan that includes lifestyle changes.

Myth: Telehealth providers can’t properly monitor patients on these medications.

Reality: Quality telehealth programs include regular follow-up appointments, monitoring of side effects, and may require periodic lab work—similar to in-person care. Many patients find that telehealth actually increases their adherence to treatment due to the convenience of follow-up visits.

Red Flags to Watch For

Not all telehealth weight loss services are created equal. Be wary of platforms that:

1. Guarantee a prescription without a thorough evaluation
2. Offer ‘compounded’ versions of semaglutide (note: in May 2025, the FDA banned routine compounding of semaglutide for weight loss)
3. Don’t schedule regular follow-ups or monitoring
4. Lack transparency about provider credentials or state licensure
5. Skip discussions about potential risks and side effects
6. Require you to waive important rights or lack a physical address

What to Expect From a Legitimate Telehealth Weight Loss Program

When you choose a reputable provider like Klarity Health, here’s what to expect:

1. Comprehensive Initial Evaluation: A detailed medical history, review of current medications, discussion of weight-related health concerns, and assessment of BMI and other vital statistics.

2. Medical Necessity Determination: Providers will verify if you meet clinical criteria for medication (generally BMI ≥30 or ≥27 with related conditions).

3. Treatment Plan Development: If medication is appropriate, your provider will create a personalized plan that includes medication, lifestyle recommendations, and monitoring parameters.

4. Regular Follow-up Care: Expect check-ins to monitor progress, adjust dosing if needed, and address any side effects. Most states require follow-up at least every 3 months.

5. Ongoing Support: Quality telehealth programs provide resources for diet, exercise, and behavioral changes to complement medication therapy.

6. Insurance Navigation: Help understanding coverage options, prior authorizations, and alternatives if insurance doesn’t cover these medications.

The Klarity Health Difference

At Klarity Health, we’re committed to providing accessible, high-quality telehealth care for weight management. Our approach includes:

• Provider Availability: Access to licensed physicians and advanced practice providers who specialize in weight management
• Transparent Pricing: Clear information about costs, with no hidden fees
• Insurance Options: We accept both insurance and cash pay, giving you flexibility
• Comprehensive Care: Medication management alongside lifestyle guidance and support
• Regulatory Compliance: We stay up-to-date with all state and federal telehealth regulations

Looking Ahead: The Future of Telehealth for Weight Management

The landscape for telehealth prescribing of weight loss medications continues to evolve. Many states are moving toward more telehealth-friendly policies as the effectiveness and convenience of virtual care becomes increasingly evident.

Patients should remain aware that regulations can change. If you move to a different state while under treatment, your provider must be licensed in your new location. Many telehealth companies, including Klarity Health, have providers licensed in multiple states to accommodate patient mobility.

Conclusion: Is Telehealth Right for Your Weight Loss Journey?

Telehealth offers a convenient, effective way to access weight loss medications for qualifying patients. While state regulations create some variation in how these services are delivered, the overall trend is toward greater accessibility and convenience.

For those who meet medical criteria for GLP-1 medications and prefer the convenience of virtual appointments, telehealth provides a legitimate pathway to treatment. By choosing a reputable provider like Klarity Health that prioritizes both regulatory compliance and quality care, patients can access these innovative medications while receiving the support they need for long-term success.

Ready to explore whether telehealth weight loss treatment

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid